molybdenum has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Li, C; Li, D; Li, J; Qi, Y; Sun, J; Tian, R; Yang, W | 1 |
1 other study(ies) available for molybdenum and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Antileukemic activity of an arsenomolybdate in the human HL-60 and U937 leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Blotting, Western; Caspase 3; Cell Cycle; Cell Proliferation; Drug Stability; Flow Cytometry; Fluorescence; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Molybdenum; U937 Cells | 2017 |